Vaping and Teens: Strategies to Help Stem the Tide
Credit(s): 1.00 (60 min)
Release Date: Jan 21, 2020
Expiration Date: Jan 21, 2021
CME / AMA PRA Category 1 Credit™
CME / AAPA Category 1 CME Credits
MOC / ABIM MOC Part 2 Credit
CNE / Nursing Contact Hours
MIPS Improvement Activity Under MACRA
Electronic cigarettes (E-cigarettes) were first introduced into the US in 2007. Since then, there has been a dramatic increase in their use by adolescents and young adults. In 2015, “ever-use” of E-cigarettes reached 40% of middle- and high-school students.
E-cigarettes deliver vaporized solutions containing nicotine or non-nicotine substances for respiratory absorption. A tank or cartridge contains the solution to be vaporized, and each e-cigarette includes a heating element with an electronic power source. While E-cigarettes are marketed as a healthier alternative to smoking, their use exposes young people to nicotine and its adverse effects (including effects on the developing brain) and to carcinogens produced by the combustion of carrier agents, which may include propylene glycol and/or a vegetable glycerin.
Reports of pulmonary injury, renal disease, increased risk of cardiovascular disease, and a recent death linked to E-cigarettes makes it imperative that clinicians understand these devices and the extent of their use by adolescents and young adults. This activity will prepare clinicians to ask their patients about E-cigarette use, and counsel young people with respect to these devices and their impacts on health.
Welcome and Introductions
Prevalence of E-cigarette Use in Pre-teens and Adolescents
Adverse Events Associated with E-cigarette Use
Counseling Pre-teens and Adolescents on E-cigarette Use
This activity is intended for the community-based primary care team, including physicians, physician assistants, and nurse practitioners.
This program is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing
At the conclusion of this activity, participants should be able to:
Discuss epidemiologic and sociologic data regarding exposure of pre-teens and adolescents to e-cigarettes
Recognize adverse events associated with the use of e-cigarettes
Develop strategies to initiate a discussion about e-cigarettes with pre-teens and adolescents and provide evidence-based education and counseling
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please email: email@example.com.
Brian Jenssen, MD, MSHP
Assistant Professor, Department of Pediatrics
Perelman School of Medicine at the University of Pennsylvania
Primary Care Pediatrician and Medical Director, Value‐Based Care
Children’s Hospital of Philadelphia (CHOP)
Brian Jenssen, MD, MSHP is a faculty member at PolicyLab at Children’s Hospital of Philadelphia (CHOP), an Assistant Professor in the Department of Pediatrics at the University of Pennsylvania, a practicing primary care pediatrician at CHOP, and Medical Director of Value-Based Care for CHOP’s Care Network (a primary care network for 260,000 pediatric patients in Pennsylvania and New Jersey). Dr. Jenssen’s research involves the use of behavioral economics, health information technology, and population health management techniques to protect children from secondhand smoke exposure and tobacco use.
Dr. Jenssen was a Clinical and Translational Science Institute Student Fellow through the National Institutes of Health, conducting research in tobacco policy, smoking cessation, and adolescent use of social media. He has worked extensively with the American Academy of Pediatrics (AAP) and the Julius B. Richmond Center of Excellence on a variety of tobacco policy efforts, and currently serves as an executive member of the newly formed AAP Section on Tobacco Control.
He holds a bachelor's degree from Davidson College, received his medical degree from the University of Rochester School of Medicine and Dentistry, and is board-certified in pediatrics. He completed a residency in pediatrics and recently served as Chief Resident at CHOP. From 2014 to 2016, Dr. Jenssen was a Robert Wood Johnson Foundation Clinical Scholar at the University of Pennsylvania, where he also earned his Masters in Health Policy Research.
Jonathan D. Klein, MD, MPH
American Academy of Pediatrics Julius B. Richmond Center of Excellence
Savithri and Samuel Raj Endowed Professor
Executive Vice Head, Department of Pediatrics
University of Illinois at Chicago School of Medicine
Jonathan D. Klein, MD, MPH is the Savithri and Samuel Raj Endowed Professor and Executive Vice Head of the Department of Pediatrics at the University of Illinois at Chicago School of Medicine. He is a pediatrician and health-services researcher specializing in access to care, preventive care guidelines, and tobacco control. He attended Brandeis University, New Jersey Medical School, and Harvard School of Public Health, and trained at the New England Medical Center and the University of North Carolina.
Dr. Klein served on the faculty at the University of Rochester from 1992-2009. From 2009-2017, he was Associate Executive Director of the American Academy of Pediatrics and, from 2005-2017, he was the Principal Investigator and founding Director of the American Academy of Pediatrics Julius B. Richmond Center of Excellence, where he currently serves as Scientific Director. The Richmond Center of Excellence is dedicated to protecting children from tobacco and secondhand smoke.
His research addresses access and quality of adolescent healthcare, preventive care delivery, survey methods, and tobacco control. Dr. Klein is immediate past Chair of NCD Child, a global coalition advocating for inclusion of children and youth in the “Non-Communicable Disease (NCD)” and “Sustainable Development Goals (SDGs)” agendas. He also serves as North American Vice President of the International Association for Adolescent Health and as an elected member of the International Pediatric Association Executive Committee.
ABIM MOC DESIGNATION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
MIPS CREDIT DESIGNATION STATEMENT
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
AAFP CREDIT DESIGNATION
This Enduring Material activity, Vaping and Teens: Strategies to Help Stem the Tide , has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 01/21/2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
JOINT PROVIDER STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Rockpointe Corporation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSING CREDIT DESIGNATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
PHYSICIAN ASSISTANT CREDIT DESIGNATION
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 1/21/2021. PAs should only claim credit commensurate with the extent of their participation.
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.
Steering Committee Disclosures
The faculty and steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Brian Jenssen, MD, MSHP: Stock Shareholder: Founder of ProNoto, LLC
Jonathan D. Klein, MD, MPH: Nothing to disclose
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Terry Ann Glauser, MD, MPH; Blair St. Amand; Lindsay Scott, PT, DPT, ATC; Ashley Marostica, MSN, RN, CCM; Brian Jack, MD; PIM Planners and Managers: Nothing to disclose
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an internet browser capable of playing an HTML5 video.
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test, with a score of 80% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
Provided by the Postgraduate Institute for Medicine
This activity is not supported by any commercial interest or grantor.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) and the New FDA Blueprint
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.